跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 111 条关于
“SONIA”
全部
111
临床试验
68
药物
2
机构
7
资讯
34
去年
SONIA Trial: Delaying CDK4/6 Inhibitors in Advanced Breast Cancer Shows Similar Survival, Reduced Costs
去年
SONIA Trial Reveals Optimal Timing for CDK4/6 Inhibitors in Advanced Breast Cancer Treatment
去年
Delaying CDK4/6 Inhibitors in Breast Cancer Reduces Toxicity Without Compromising Outcomes
12年前
Innovative Strategies for Patient Recruitment in Rare Disease Trials: Lessons from the Alkaptonuria Experience
去年
Meta-Analysis Reveals Mixed Benefits of First-Line vs. Second-Line CDK4/6 Inhibitor Therapy in HR+/HER2- Metastatic Breast Cancer
2年前
Innate Pharma Announces Advancement of Sanofi-Developed NK Cell Engager SAR443579/IPH6101 to Phase 2 for Blood Cancer Patients
去年
Epsilogen Acquires TigaTx to Create Leading Pan-Isotype Cancer Antibody Company
去年
Innate Pharma Doses First Patient in Phase 1 Trial of Nectin-4-Targeting ADC IPH4502 for Advanced Solid Tumors
去年
ICON Launches Comprehensive Patient-Centric Outcome Measures Solution for Clinical Trials
去年
Innate Pharma's IPH4502, a Nectin-4-Targeting ADC, Receives FDA IND Clearance for Phase 1 Solid Tumor Trial
第 1 页,共 4 页
上一页
下一页